Expression of bone turnover markers in patients with tuboovarian carcinoma exposed to platinum-based chemotherapy ± bevacizumab

被引：0
|
作者：
Kurbacher, C. M. [1 ]
Huhmann, A. [1 ]
Herz, S. [1 ]
Kurbacher, A. T. [1 ]
Monreal, K. [1 ]
Kurbacher, J. A. [2 ]
机构：
[1] Gynecol Ctr Bonn Friedenspl, Gynecol Oncol, Bonn, Germany
[2] Gynecol Ctr Bonn Friedenspl, Gen Gynecol & Obstet, Bonn, Germany
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-0268
引用
收藏
页码：750 / 750
页数：1
相关论文
共 50 条
  • [21] The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy
    Bamias, A
    Efstathiou, E
    Moulopoulos, LA
    Gika, D
    Hamilos, G
    Zorzou, MP
    Kakoyiannis, C
    Kastritis, E
    Bozas, G
    Papadimitriou, C
    Dimopoulos, MA
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 307 - 313
  • [22] Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma
    Malandrino, Pasqualino
    Al Ghuzlan, Abir
    Castaing, Marine
    Young, Jacques
    Caillou, Bernard
    Travagli, Jean-Paul
    Elias, Dominique
    de Baere, Thierry
    Dromain, Clarisse
    Paci, Angelo
    Chanson, Philippe
    Schlumberger, Martin
    Leboulleux, Sophie
    Baudin, Eric
    ENDOCRINE-RELATED CANCER, 2010, 17 (03) : 797 - 807
  • [23] Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma
    Yumioka, Tetsuya
    Honda, Masashi
    Shimizu, Ryutaro
    Teraoka, Shogo
    Yamaguchi, Noriya
    Kawamoto, Bunya
    Iwamoto, Hideto
    Morizane, Shuichi
    Hikita, Katsuya
    Takenaka, Atsushi
    ANTICANCER RESEARCH, 2021, 41 (11) : 5767 - 5773
  • [24] Do elderly patients with advanced urothelial carcinoma benefit from platinum-based chemotherapy?
    Hans von der Maase
    Nature Clinical Practice Urology, 2005, 2 : 318 - 319
  • [25] Platinum-based chemotherapy with or without thoracic radiation therapy in patients with unresectable thymic carcinoma
    Nakamura, Y
    Kunitoh, H
    Kubota, K
    Sekine, I
    Shinkai, T
    Tamura, T
    Kodama, T
    Sumi, M
    Kohno, S
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (09) : 385 - 388
  • [26] MULTIPLE BIOLOGICAL MARKERS IN GERM-CELL TUMOR PATIENTS TREATED WITH PLATINUM-BASED CHEMOTHERAPY
    PERERA, FP
    MOTZER, RJ
    TANG, D
    REED, E
    PARKER, R
    WARBURTON, D
    ONEILL, P
    ALBERTINI, R
    BIGBEE, WL
    JENSEN, RH
    SANTELLA, R
    TSAI, WY
    SIMONCEREIJIDO, G
    RANDALL, C
    BOSL, G
    CANCER RESEARCH, 1992, 52 (13) : 3558 - 3565
  • [27] Expression of UCP2 is associated with the sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Inoue, Yuta
    Fukuda, Takeshi
    Kawanishi, Masaru
    Shimomura, Masahiro
    Wada, Takuma
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S9 - S9
  • [28] Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy
    Ronchi, Cristina L.
    Sbiera, Silviu
    Kraus, Luitgard
    Wortmann, Sebastian
    Johanssen, Sarah
    Adam, Patrick
    Willenberg, Holger S.
    Hahner, Stefanie
    Allolio, Bruno
    Fassnacht, Martin
    ENDOCRINE-RELATED CANCER, 2009, 16 (03) : 907 - 918
  • [29] Expression of UCP2 is associated with sensitivity to platinum-based chemotherapy for ovarian serous carcinoma
    Kawanishi, Masaru
    Fukuda, Takeshi
    Shimomura, Masahiro
    Inoue, Yuta
    Wada, Takuma
    Tasaka, Reiko
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2018, 15 (06) : 9923 - 9928
  • [30] Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma
    Zhang, Tian
    Tan, Alan
    Shah, Amishi Y.
    Iyer, Gopa
    Morris, Valerie
    Michaud, Sebastien
    Sridhar, Srikala S.
    ONCOLOGIST, 2024, 29 (12): : 1003 - 1013
12345